About this trial
A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
Eligibility criteria
Qualifiers
Willing to provide informed consent
Male or female, aged 40 and up (inclusive) at the time of enrollment
Clinical suspicion of myocardial ischemia that clinician desired cardiac PET
Completed cardiac PET within 2 weeks prior to study enrollment
Disqualifiers
Patients unable to fit into CardioFlux device.
Patients unable to lie supine for 5 minutes.
Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable
Ongoing atrial fibrillation or atrial flutter
Trial design
Treatments tested in this trial
- CardioFlux Magnetocardiography